0001562230-25-000094.txt : 20250813 0001562230-25-000094.hdr.sgml : 20250813 20250813124942 ACCESSION NUMBER: 0001562230-25-000094 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250813 DATE AS OF CHANGE: 20250813 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91540 FILM NUMBER: 251210136 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital International Investors CENTRAL INDEX KEY: 0001562230 ORGANIZATION NAME: EIN: 951411037 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: Capital Research & Management Co - Division 3 DATE OF NAME CHANGE: 20121114 SCHEDULE 13G 1 primary_doc.xml SCHEDULE 13G 0001562230 XXXXXXXX LIVE Common Stock 06/30/2025 0001802768 Royalty Pharma PLC G7709Q104 110 EAST 59TH STREET NEW YORK X1 10022 Rule 13d-1(b) Capital International Investors DE 23006820 0 23111998 0 23111998.00 5.5 IA Royalty Pharma PLC 110 EAST 59TH STREET, NEW YORK, NY 10022 Capital International Investors 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 N/A N IA 23,111,998 ** **Capital International Investors ("CII") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 23,111,998 shares or 5.5% of the 421,370,657 shares believed to be outstanding. 5.5 23,006,820 0 23,111,998 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Capital International Investors Jae Won Chung 08/12/2025